D

Daewoong Co Ltd
KRX:003090

Watchlist Manager
Daewoong Co Ltd
KRX:003090
Watchlist
Price: 20 600 KRW 0.49% Market Closed
Market Cap: 842.3B KRW
Have any thoughts about
Daewoong Co Ltd?
Write Note

Daewoong Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daewoong Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
Daewoong Co Ltd
KRX:003090
Cost of Revenue
-â‚©889.4B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
Yuhan Corp
KRX:000100
Cost of Revenue
-â‚©1.3T
CAGR 3-Years
2%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
SK Biopharmaceuticals Co Ltd
KRX:326030
Cost of Revenue
-â‚©34.1B
CAGR 3-Years
-158%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Cost of Revenue
-â‚©1T
CAGR 3-Years
-10%
CAGR 5-Years
-9%
CAGR 10-Years
-11%
Hanmi Pharm Co Ltd
KRX:128940
Cost of Revenue
-â‚©691.3B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
-8%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cost of Revenue
-â‚©109.5B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
No Stocks Found

Daewoong Co Ltd
Glance View

Market Cap
842.3B KRW
Industry
Pharmaceuticals

Daewoong Co., Ltd. engages in the management of its subsidiaries. The company is headquartered in Seongnam, Gyeonggi-Do. The firm operates its business mainly through subsidiaries including Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd, Daewoong Development Co Ltd, and Hanall Biopharma Co Ltd. Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd and Hanall Biopharma Co Ltd are engaged in the manufacture and sale of pharmaceuticals. Daewoong Development Co Ltd is engaged in real estate rental and supply business. In addition, IDS&Trust Co Ltd manufactures and sells communication-related devices. Daewoong Life Science Co Ltd is engaged in food processing and sales. Pampaeg Co Ltd is engaged in the packaging business of quasi-drugs. Daewoong Management Development Institute Co Ltd is engaged in management and industrial training projects.

Intrinsic Value
24 409.56 KRW
Undervaluation 16%
Intrinsic Value
Price
D

See Also

What is Daewoong Co Ltd's Cost of Revenue?
Cost of Revenue
-889.4B KRW

Based on the financial report for Sep 30, 2024, Daewoong Co Ltd's Cost of Revenue amounts to -889.4B KRW.

What is Daewoong Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-8%

Over the last year, the Cost of Revenue growth was -4%. The average annual Cost of Revenue growth rates for Daewoong Co Ltd have been -7% over the past three years , -4% over the past five years , and -8% over the past ten years .

Back to Top